ST8SIA6 and chronic myelogenous leukemia, BCR-ABL1 positive: ST8SIA6 is a member of sialytransferases (STs), and aberrant sialylation of the cell surface glycoprotein is linked with multidrug resistance in AML and CML [54,55].